UiPath (NYSE:PATH) Trading Up 0.9%

Shares of UiPath Inc. (NYSE:PATH) were up 0.9% during trading on Wednesday . The stock traded as high as $12.09 and last traded at $12.04. Approximately 1,389,684 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 9,836,723 shares. The stock had previously closed at $11.93.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Morgan Stanley cut their price objective on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating for the company in a report on Thursday, May 30th. KeyCorp reiterated a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. Scotiabank dropped their price objective on UiPath from $30.00 to $25.00 and set a “sector perform” rating for the company in a report on Wednesday, May 29th. Truist Financial reiterated a “hold” rating and set a $14.00 target price (down from $32.00) on shares of UiPath in a research report on Thursday, May 30th. Finally, William Blair cut shares of UiPath from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 30th. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, UiPath has a consensus rating of “Hold” and a consensus target price of $18.06.

UiPath Stock Up 1.8 %

The stock has a market capitalization of $6.95 billion, a price-to-earnings ratio of -75.25 and a beta of 0.85. The stock has a 50 day moving average price of $16.56 and a 200 day moving average price of $21.01.

UiPath (NYSE:PATH) last posted its earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.03). UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The firm had revenue of $335.11 million for the quarter, compared to analyst estimates of $332.84 million. Sell-side analysts forecast that UiPath Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Activity at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $19.79, for a total transaction of $791,600.00. Following the transaction, the chief financial officer now directly owns 946,848 shares of the company’s stock, valued at approximately $18,738,121.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 22.37% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of PATH. Mark Sheptoff Financial Planning LLC acquired a new stake in UiPath during the fourth quarter worth approximately $25,000. HighMark Wealth Management LLC bought a new stake in shares of UiPath in the 4th quarter valued at $27,000. ORG Partners LLC lifted its position in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after acquiring an additional 1,112 shares during the period. Cypress Capital Management LLC WY bought a new position in UiPath during the fourth quarter worth $29,000. Finally, GAMMA Investing LLC acquired a new stake in UiPath in the fourth quarter worth $36,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.